The Omicron variant of coronavirus is spreading quickly in several countries where it has been discovered. Even if it causes only mild disease — and that's far from certain — that could still mean many people end up in the hospital and dying.
"Given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs," WHO added. A new study out Monday from researchers at Oxford University adds to evidence that two of the main vaccines deployed against Covid-19 -- the AstraZeneca vaccine used widely in Britain and around the world but not in the US,and the Pfizer/BioNTech vaccine used widely in the US, Europe and elsewhere -- won't protect people as well against the Omicron variant.
Disease modelers at the London School of Hygiene and Tropical Medicine released a report Saturday that projects infections in England passing last winter's peak in terms of daily numbers. This could translate into double the number of daily hospital admissions as seen last year, they wrote in a pre-print report posted online.
While only a few cases have been identified in the US so far, there is little reason to think it will not spread in the US as it has elsewhere.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: manilabulletin - 🏆 25. / 51 Read more »